Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06381362
Recruiting Observational

Italian Registry of Minimally Invasive Pancreatic Surgery

NCT06381362 · tracked via the Priya Life Science Italy tracker
Sponsor
Associazione Italiana per lo Studio del Pancreas
Phase
Observational
Started
2019-02-28
Last updated
2024-04-24

Condition(s) studied

Pancreatic Surgery

Investigational drug(s) / intervention(s)

Minimally invasive pancreatic surgery

Minimally invasive pancreatic surgery: Minimally invasive pancreatic surgery

Study summary

Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age \> 18 years; * Underwent minimally invasive pancreatic surgery Exclusion Criteria: * Pregnant woman * Minor or unable to give informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Giovanni Capretti Milan Italy Recruiting

More Associazione Italiana per lo Studio del Pancreas trials in Italy

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) Active, not recruiting
Registry of Subjects at Risk of Pancreatic Cancer Recruiting
Familial Pancreatic Cancer PROPHilation Program in Italy Recruiting
Italian Registry Chronic Pancreatitis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06381362 on ClinicalTrials.gov ↗ ← All trials in Italy